16 researchers who have recently gained their PhDs will do research at foreign research institutions thanks to a Rubicon grant from NWO. The Rubicon programme is intended to give young, highly promising researchers the opportunity to gain international research experience.

The majority of the researchers will go abroad for a period of 24 months. For example, they will investigate causes of reduced fertility at a later age, how the brain distinguishes reality from fantasy, grammatical relationships in indigenous languages from the Amazon region, and how our public transport can be better optimised from the travellers viewpoint.
 
Within the domain medical Sciences these are the young researchers  who received a Rubicon grant:

Good bacteria and healthy noses

Dr R (Rob) van Dalen (m), Utrecht University ‐> Germany, Eberhard Karls University of Tübingen, Interfaculty Institute of Microbiology and Infection, 24 months
If the wrong bacteria can live in our nose, then we suffer from respiratory inflammations and allergies. This project will investigate how our immune system recognises the bacteria in our nose and can therefore attack the wrong bacteria, but support the good ones.

Advanced puzzling : the genetic complexity of psychiatric disorders

Dr M. (Marieke) Klein (f), Donders Institute and Radboudumc, Radboud University -> United States, University of California San Diego, Department of Psychiatry, 24 months
DNA mutations often have serious consequences and yet millions of changes take place without any apparent consequences. Together they form a key for the development of psychiatric disorders. The researcher will develop new analysis methods to investigate the interaction of these genetic variants.

Beta pods for the treatment of type 1 diabetes

Dr S.G. (Sami) Mohammed (m), Radboudumc -> United States, Joslin Diabetes Center, Islet Cell and Regenerative Biology section, 18 months
Beta pods are specially made implants to transplant insulin producing beta cells for type 1 diabetes. The aim of this project is to investigate the effectiveness of the beta pod in maintaining the balance of blood sugar values during a preclinical study.

Releasing all brakes against cancer

Dr J.G.C. (Janneke) Peeters (f), UMC Utrecht -> United States, University of California, Berkeley, Molecular and Cellular Biology Department, 24 months
Neuroblastoma is a highly lethal form of childhood cancer because our immune system cannot attack the tumour. The researcher will investigate how cells that inhibit the immune system contribute to neuroblastoma and will try to find mechanisms that can eliminate these cells.

Acute leukaemia treatment: double-edge sword

Dr J. (Jurjen) Versluis (m), Erasmus Medical Center Cancer Institute -> United States, Harvard Medical School – Dana-Farber Cancer Institute, Department of Hemato-Oncology, 12 months
A tailored approach for the treatment of the individual older patient with acute myeloid leukaemia is desperately needed. The researcher will develop an innovative complex risk model to better inform doctors and patients about treatment choices.

More Information

To top
Direct naar: InhoudSkip to navigationSkip to website footer